Type 2 diabetes mellitus (T2DM) greatly increases cardiovascular risk. Primary and secondary cardiovascular
prevention lead to lower cardiovascular events, improved quality of life and lower costs related to complications. Objective:
To est
Prevalence of the Use of Aspirin and Statins for Preventing Cardiovascular Events in the Colombian Population with Type 2 Diabetes mellitus: Comparison of 2008 and 2018
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: Manuel E. Machado-Duque, Diego Arturo Garcia, Melissa Hiromi Emura-Vélez, Andrés Gaviria-Mendoza, and Jorge E. Machado-Alba
- Idiomas: Inglés
- Palabras clave: "diabetes mellitus tipo 2, enfermedades cardiovasculares, aspirina, inhibidores de la hidroximetilglutaril-CoA reductasa, hipolipidemiante agentes, farmacoepidemiologíaType 2 diabetes mellitus, cardiovascular diseases, aspirin
Machado-Duque ME, Garcia DA, Emura-Vélez MH, Gaviria-Mendoza A, Machado-Alba JE. Prevalence of the Use of Aspirin and Statins for Preventing Cardiovascular Events in the Colombian Population with Type 2 Diabetes Mellitus: Comparison of 2008 and 2018. Jour Enlace: https://doi.org/10.1177/21501327211007015
